KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsDividends Paid - CommonFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and Equipment
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Diversified Healthcare Trust (DHC) Gains from Investment Securities (2016 - 2025)

Diversified Healthcare Trust (DHC) has disclosed Gains from Investment Securities for 16 consecutive years, with -$250000.0 as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Gains from Investment Securities fell 101.66% year-over-year to -$250000.0, compared with a TTM value of $124.1 million through Dec 2025, up 8765.57%, and an annual FY2024 reading of $15.5 million, changed N/A over the prior year.
  • Gains from Investment Securities was -$250000.0 for Q4 2025 at Diversified Healthcare Trust, down from $110.1 million in the prior quarter.
  • Across five years, Gains from Investment Securities topped out at $327.8 million in Q4 2021 and bottomed at -$13.2 million in Q2 2024.
  • Average Gains from Investment Securities over 5 years is $25.6 million, with a median of $200000.0 recorded in 2021.
  • The sharpest move saw Gains from Investment Securities surged 163997.0% in 2021, then tumbled 836.43% in 2024.
  • Year by year, Gains from Investment Securities stood at $327.8 million in 2021, then tumbled by 102.26% to -$7.4 million in 2022, then surged by 83.34% to -$1.2 million in 2023, then soared by 1320.92% to $15.1 million in 2024, then crashed by 101.66% to -$250000.0 in 2025.
  • Business Quant data shows Gains from Investment Securities for DHC at -$250000.0 in Q4 2025, $110.1 million in Q1 2025, and $15.1 million in Q4 2024.